D
Dolores Lopez-Terrada
Researcher at Baylor College of Medicine
Publications - 151
Citations - 6813
Dolores Lopez-Terrada is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Hepatoblastoma & Sarcoma. The author has an hindex of 35, co-authored 132 publications receiving 5577 citations. Previous affiliations of Dolores Lopez-Terrada include Children's Hospital of Eastern Ontario & University of Southern California.
Papers
More filters
Journal ArticleDOI
A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS–family transcription factor, ERG
Poul H. Sorensen,Stephen L. Lessnick,Dolores Lopez-Terrada,Xian F. Liu,Timothy J. Triche,Christopher T. Denny +5 more
TL;DR: Findings suggest that fusion of EWS to different members of the ETS family of transcription factor genes may result in the expression of similar disease phenotypes.
Journal ArticleDOI
Specific Mutations in the β-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid Tumors
Alexander J. Lazar,Daniel Tuvin,Shohrae Hajibashi,Sultan Habeeb,Svetlana Bolshakov,Empar Mayordomo-Aranda,Carla L. Warneke,Dolores Lopez-Terrada,Raphael E. Pollock,Dina Lev +9 more
TL;DR: Patients harboring CTNNB1 (45F) mutations are at particular risk for recurrence and therefore may especially benefit from adjuvant therapeutic approaches.
Journal ArticleDOI
Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors.
D. Williams Parsons,Angshumoy Roy,Yaping Yang,Tao Wang,Sarah Scollon,Katie Bergstrom,Robin A. Kerstein,Stephanie Gutierrez,Andrea K. Petersen,Abhishek Bavle,Frank Y. Lin,Dolores Lopez-Terrada,Federico A. Monzon,Federico A. Monzon,M. John Hicks,Karen W. Eldin,Karen W. Eldin,Norma M. Quintanilla,Norma M. Quintanilla,Adekunle M. Adesina,Adekunle M. Adesina,Carrie A. Mohila,Carrie A. Mohila,William E. Whitehead,William E. Whitehead,Andrew Jea,Andrew Jea,Sanjeev A. Vasudevan,Sanjeev A. Vasudevan,Jed G. Nuchtern,Uma Ramamurthy,Amy L. McGuire,Susan G. Hilsenbeck,Jeffrey G. Reid,Donna M. Muzny,David A. Wheeler,Stacey L. Berg,Murali Chintagumpala,Christine M. Eng,Richard A. Gibbs,Sharon E. Plon +40 more
TL;DR: Combined reporting of tumor and germline WES identified diagnostic and/or potentially actionable findings in nearly 40% of newly diagnosed pediatric patients with solid tumors.
Journal ArticleDOI
Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials
Piotr Rutkowski,Martine Van Glabbeke,Cathryn Rankin,Wlodzimierz Ruka,Brian P. Rubin,Maria Debiec-Rychter,Alexander J. Lazar,Hans Gelderblom,Raphael Sciot,Dolores Lopez-Terrada,Peter Hohenberger,Allan T. van Oosterom,Scott M. Schuetze +12 more
TL;DR: Imatinib is active in DFSP harboring t(17;22) including fibrosarcomatous DFSP, with objective response rate approaching 50%.
Journal ArticleDOI
Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK
Adrián Mariño-Enríquez,Wei Lien Wang,Angshumoy Roy,Dolores Lopez-Terrada,Alexander J. Lazar,Christopher D.M. Fletcher,Cheryl M. Coffin,Jason L. Hornick +7 more
TL;DR: The epithelioid variant of IMT with nuclear membrane or perinuclear ALK is a distinctive intra-abdominal sarcoma with a predilection for male patients, unlike conventional IMT, abundant myxoid stroma and prominent neutrophils are common.